Argonaute RNA - Crunchbase Company Profile & Funding

Q: Who invested in Argonaute RNA?

Argonaute RNA has 4 investors including The Fink Family Office And Empirical Ventures.

Q: When was the last funding round for Argonaute RNA?

Argonaute RNA closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Argonaute RNA raised to date?

Argonaute RNA has raised obfuscated.

Overview

Argonaute RNA

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Argonaute RNA

CB Rank

79170

Argonaute RNA company research projects build on existing intellectual property.

Founded

obfuscation

Private

Venture - Series Unknown

Bristol, Bristol, City of, United Kingdom

11-50

argonauterna.com/

Biotechnology

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Alexander Fink: Director

Details

Legal Name

ARGONAUTE RNA LIMITED

Operating Status

Active

Company Type

For Profit

About the Company

Argonaute RNA is pursuing a number of therapeutic opportunities in RNA interference. RNAi harnesses a cell mechanism that inhibits the expression of a specific gene and thereby inhibits the production of a specific protein. Argonaute RNA research projects build on existing intellectual property. They show how their proprietary modification of small

interfering RNA (siRNA) allows safe and effective ways to silence specific gene expression.

Phone Number

+44 (0)117 974 2561

Contact Email

info@argonauterna.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

PULSE siRNA™

A siRNA therapy platform designed for short-duration gene silencing with rapid recovery, stability, and potency without chemical modification.

Argo Dual siRNA

A bispecific siRNA platform combining two gene-silencing agents in one molecule to target complex diseases by silencing multiple genes simultaneously.

Research & Development

Argonaute RNA is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Argonaute RNA	4	obfuscated obfuscation	Development Bank of Wales	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Argonaute RNA	4	obfuscated obfuscation	Development Bank of Wales	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Argonaute RNA	4	obfuscated obfuscation	Development Bank of Wales	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Argonaute RNA	4	obfuscated obfuscation	Development Bank of Wales	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Argonaute RNA	4	obfuscated obfuscation	Development Bank of Wales	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Argonaute RNA	4	obfuscated obfuscation	Development Bank of Wales	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Argonaute RNA	4	obfuscated obfuscation	Development Bank of Wales	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Argonaute RNA	4	obfuscated obfuscation	Development Bank of Wales	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Argonaute RNA	4	obfuscated obfuscation	Development Bank of Wales	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Argonaute RNA	4	obfuscated obfuscation	Development Bank of Wales	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
The Fink Family Office	—	Venture Round - Argonaute RNA	—
The Fink Family Office	—	Venture Round - Argonaute RNA	—
The Fink Family Office	—	Venture Round - Argonaute RNA	—
The Fink Family Office	—	Venture Round - Argonaute RNA	—
The Fink Family Office	—	Venture Round - Argonaute RNA	—